U.S. Communications Stock News

If you are wondering whether Sarepta Therapeutics at US$20.80 is starting to look like value or still carries too much risk, the recent share price and fundamentals give you a lot to weigh up. The stock has been under pressure, with returns of 0.4% decline over 7 days, 9.9% decline over 30 days, 2.4% decline year to date, 43.0% decline over 1 year and 82.7% decline over 3 years, while the 5 year return sits at 71.3% decline. Recent news around Sarepta Therapeutics has focused on its position...

National Health Investors (NYSE:NHI) is selling its entire skilled nursing facility portfolio for $560 million. The company plans to redeploy proceeds into private-pay senior housing, including a seven-property portfolio in Colorado. This shift reduces exposure to skilled nursing and increases focus on private-pay assets that management views as offering more attractive risk adjusted returns. For investors watching NYSE:NHI, this move comes with the stock recently closing at $75.07 and...

Pacific Biosciences of California (PACB) has just posted its FY 2025 numbers, with Q4 revenue at US$44.6 million and a basic EPS loss of US$0.13 set against trailing twelve month revenue of US$160.0 million and a TTM basic EPS loss of US$1.82. Over the past six reported quarters, the company has seen quarterly revenue move between US$37.2 million and US$44.6 million, while basic EPS has ranged from a small profit of US$0.01 in FY 2024 Q4 to a loss of US$1.44 in FY 2025 Q1. This leaves...

Genius Sports (GENI) opened Q1 2026 with revenue of US$188 million, a basic EPS loss of US$0.21 per share, and net income loss of US$55 million, setting a cautious tone around near term profitability. The company has seen quarterly revenue move from US$144 million in Q1 2025 to US$188 million in Q1 2026, while basic EPS shifted from a loss of US$0.03 to a loss of US$0.21 over the same period. This puts the focus squarely on how efficiently that extra revenue is translating into results. For...

Why National Storage Affiliates Trust is on investors’ radar National Storage Affiliates Trust (NSA) has drawn attention after its recent share performance, with the stock showing positive returns over the past week, month and past 3 months. This has invited closer inspection from income focused REIT investors. See our latest analysis for National Storage Affiliates Trust. While the 1 day share price return was slightly negative, the recent 30 day and year to date share price returns of...

ACADIA Pharmaceuticals (ACAD) opened 2026 with Q1 revenue of $268.1 million and basic EPS of $0.02, against a backdrop of trailing twelve month revenue of $1.1 billion, basic EPS of $2.22 and net income of $375.7 million. Over recent quarters, the company has seen revenue move from $244.3 million in Q1 2025 to $268.1 million in Q1 2026, while quarterly basic EPS has ranged from $0.11 to $1.62. These results come within a period of margin expansion and earnings growth that investors now need...

If you are wondering whether Ouster's share price still offers value after a strong run, it helps to start by lining up the recent returns with what the current valuation really implies. Ouster's stock closed at US$24.51, with returns of 26.8% over 30 days, 4.9% year to date and 183.4% over 1 year, while the last 7 days show a 9.1% decline and the 5 year figure sits at a 70.9% loss. Taken together, these figures suggest investors have been reassessing both potential and risk over different...

This article considers whether Coinbase Global's recent share price suggests a potential bargain or already reflects its current story, by comparing its value against several common yardsticks. At a last close of US$192.96, the stock has returned 2.8% over the past week and 10.1% over the past month. It is down 18.4% year to date and has returned 219.7% over three years and 27.2% over five years. Recent headlines around Coinbase Global have focused on its role as a listed gateway to crypto...

Warner Music Group and Paramount Pictures have agreed a multi year, first look partnership to develop theatrical films based on Warner Music artists and songwriters. The deal focuses on creating new cinema projects that tap into both legendary and contemporary acts from Warner Music Group. This collaboration pairs a major recorded music company with a leading Hollywood studio to build film concepts around music IP. For investors watching NasdaqGS:WMG, this new film partnership sits...

If you are wondering whether Regeneron Pharmaceuticals at around US$709.10 is priced attractively or already reflects the story, the valuation picture is where the answers start to emerge. The stock is up 0.3% over the last 7 days, while it shows a 6.7% decline over 30 days, an 8.7% decline year to date, and a 30.2% return over the past year, which can change how investors think about both upside potential and risk. Recent headlines around Regeneron often focus on its position within large...

Atlassian (NasdaqGS:TEAM) has launched major AI native platform upgrades, highlighted by the open Teamwork Graph and new autonomous agent capabilities. The new features, including agents in Rovo and Jira, are designed to help teams plan, execute, and automate work across Atlassian and third party tools. Governance and security controls are built into the platform, targeting enterprise use cases where data access and compliance are critical. Atlassian is best known for tools like Jira and...

Wondering if Donnelley Financial Solutions at around US$44 is offering value or just noise? This article breaks down what the current price might actually mean for you. The stock recently closed at US$44.21, with returns of a 12.1% decline over 7 days, a 10.0% decline over 30 days and a 3.1% decline year to date, alongside a 17.2% decline over 1 year, a 0.2% decline over 3 years and a 73.6% gain over 5 years. Recent coverage of Donnelley Financial Solutions has focused on its role in...

Cognyte Software Ltd. previously announced a three-year subscription contract worth over US$20,000,000 with a long-standing EMEA-region customer, expanding deployment of its AI-driven analytics to handle higher data volumes and more complex investigations. The shift of this long-term relationship to a subscription model underscores recurring revenue visibility and deeper integration of Cognyte’s capabilities into mission-critical operations. Next, we’ll explore how this expanded, multi-year...

Aflac Incorporated recently reported first-quarter 2026 results, with revenue rising to US$4.35 billion and net income to US$1.02 billion, while also continuing share repurchases, maintaining its quarterly dividend, and opening a new claims office in South Portland to support Maine’s Paid Family and Medical Leave program that began paying benefits on May 1. Despite this combination of earnings growth, capital returns, and expansion into state-administered leave programs, management...

If you are wondering whether AECOM's share price reflects its true value, you are not alone. This article focuses squarely on what the current price might be asking you to pay. The stock last closed at US$81.47, with returns of a 3.1% decline over 7 days, 2.2% decline over 30 days, 15.5% decline year to date and 21.1% decline over the past year, set against longer term returns of 7.8% over 3 years and 26.4% over 5 years. Recent coverage has centered on how investors are reassessing...

If you are trying to work out whether DraftKings stock looks attractively priced or too expensive at today’s levels, you will want more than just the latest share price in front of you. The stock recently closed at US$25.22, with returns of 8.1% over 7 days and 9.9% over 30 days, while year to date and 1 year returns of negative 29.3% and negative 28.7% show a very different picture over a longer window. Recent headlines around DraftKings have largely focused on the broader US sports betting...

Q1 results and new shelf registration Beyond Meat (BYND) has drawn fresh attention after reporting first quarter 2026 results, which showed a reduced net loss alongside lower sales. This was followed shortly by a US$10.4 million shelf registration tied to an employee stock ownership plan. See our latest analysis for Beyond Meat. The stock has moved sharply around the Q1 update and ESOP shelf filing, with a 30-day share price return of 53.93% contrasting with a 1-year total shareholder return...

Zoetis (NYSE:ZTS) has cut its full year guidance after a sharp downturn in its U.S. companion animal business. Management points to higher price sensitivity among pet owners, fewer veterinary visits, and more generic competition as key pressures. The company is refocusing on integrated solutions, tighter cost controls, and operational efficiency as part of a broad reset. For investors, the reset lands on top of a steep share price pullback. Zoetis now trades at $87.31, with the stock down...

For investors wondering if Krystal Biotech at around US$296.70 is still offering value or if the easy gains are behind it, this article walks through what the current price may be implying. The stock has shown strong share price moves, with returns of 13.1% over 7 days, 12.4% over 30 days, 20.2% year to date, 116.3% over the last year, 228.5% over 3 years, and 374.4% over 5 years. These price moves sit against a backdrop of ongoing attention on Krystal Biotech's position in the...

Ultragenyx Pharmaceutical Inc. reported past first-quarter 2026 results with revenue of US$136 million, a wider net loss of US$185 million, and reaffirmed its 2026 revenue guidance of US$730 million to US$760 million while remaining on a stated path toward profitability in 2027. Management also highlighted potential 2026 approvals for two gene therapies and key late-stage data for its Angelman syndrome program, underscoring how clinical and regulatory milestones are central to its...

Gibraltar Industries (ROCK) opened Q1 2026 with total revenue of US$356.3 million and a basic EPS loss of US$0.40, setting a cautious tone around the latest numbers. The company has seen quarterly revenue move from US$246.4 million and EPS of US$0.76 in Q1 2025 through a series of US$309.5 million to US$310.9 million quarters with EPS between US$0.99 and US$1.12, before landing at US$268.7 million and EPS of US$0.40 in Q4 2025. This gives investors a clear look at how the top line has...

MGIC Investment Corporation recently reported its first-quarter 2026 results, with revenue of US$297.08 million and net income of US$165.3 million, both lower than the same period a year earlier. Despite the revenue and profit declines, MGIC’s basic and diluted earnings per share from continuing operations held around US$0.76, indicating stable per-share profitability even as overall earnings softened. Now we’ll examine how this combination of lower revenue but steady earnings per share...

Wondering if Sigma Lithium's current share price reflects its true worth, or if the recent excitement has run ahead of the fundamentals? The stock last closed at US$23.65, with returns of 7.2% over 7 days, 61.7% over 30 days, 66.4% year to date, 218.7% over 1 year and 401.5% over 5 years, while the 3 year return stands at a loss of 40.0%. Recent coverage has focused on Sigma Lithium as a lithium producer, with investors watching how sentiment around the sector and the company's development...

Eversource Energy (ES) opened 2026 with Q1 revenue of about US$4.5 billion and basic EPS of US$1.61, setting the stage against a year of sharply higher trailing earnings and wider margins. Over the last six reported quarters, quarterly revenue has ranged from US$2.8 billion to US$4.5 billion while basic EPS has moved between roughly US$0.20 and US$1.61, and on a trailing twelve month basis EPS reached US$4.69 alongside revenue of about US$13.9 billion. With trailing net margin sitting above...